மாற்றி அமைக்கத்தக்க உயிரி தொழில்நுட்பங்கள் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hematologic Malignancies Testing Market Share, Size, & Trends Analysis Report, Region, and Segment Forecasts, 2020 – 2028 emergenMay 23, 2021 1 The global Hematologic Malignancies Testing Market is forecasted to be worth USD 5.45 Billion by 2027, according to a current analysis by Emergen Research. In March 2020, Sysmex Corporation received japan marketing clearance for BGI Genomics Coronavirus kit distribution. This initiative will strengthen its position in Japan. During the forecast timeline, the Next-generation sequencing segment will hold the largest market with a CAGR of 14.8%. In next-generation sequencing, the steadily developing cohort of technologies allowing the detection of gene variations present in Rna and DNA. In the case of hematologic malignancies, such differences provide diagnostic relevance.

United statesSaudi arabiaSouth koreaAsia pacificAdaptive biotechnologies corporationSysmex corporationResearch scopeCancer genetics incInvitae corporationResearch sourcesInvivoscribe incArcherdx incTechnology outlook revenueAsuragen incNeogenomics laboratories incBio rad laboratories inc